(Q79605228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Katja E Andersson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Geoffrey S Williams

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Petter Höglund

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

516-527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

What does it take to make a natural killer?

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The Ly-49 family: genes, proteins and recognition of class I MHC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Natural killer cell receptors: the offs and ons of NK cell recognition.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Interplay of natural killer cells and their receptors with the adaptive immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The NK cell receptor repertoire: formation, adaptation and exploitation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Natural killer cell receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

How do natural killer cells find self to achieve tolerance?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Licensing of natural killer cells by host major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Missing self, NK cells, and The White Album

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

MHC class Ia molecules alone control NK-mediated bone marrow graft rejection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Cis association of Ly49A with MHC class I restricts natural killer cell inhibition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Having it both ways: MHC recognition in cis and trans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The nature of molecular recognition by T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The protean immune cell synapse: a supramolecular structure with many functions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Analysis of mechanisms by which NK cells acquire increased cytotoxicity against class I MHC-eliminated targets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Dissociation of beta 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Variable Dimerization of the Ly49A Natural Killer Cell Receptor Results in Differential Engagement of its MHC Class I Ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Alpha1/alpha2 domains of H-2D(d), but not H-2L(d), induce "missing self" reactivity in vivo--no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636693

7 January 2021

Identifiers

DOI

10.1002/EJI.200636693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17236237%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference